The impact of protons on the incidence of second malignancies in radiotherapy

Technology in Cancer Research and Treatment

Volumn 6, Issue 4 SUPPL., 2007, Pages 31-34

  Hall, Eric J ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Cancer; Neutrons; Passive modulation; Protons; Scanning beams

Indexed keywords

BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CONFERENCE PAPER; HUMAN; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RECTUM CANCER; RELATIVE BIOLOGIC EFFECTIVENESS; SECOND CANCER; STOMACH CANCER;

EID: 34548276465     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/15330346070060s405     Document Type: Conference Paper

References (17)

1. Pierce, D. A., Preston, D. L. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154, 178-186 (2000).
2. Brenner D. J., Curtis R. E., Hall E. J., et al. Second malignancies in prostate patients after radiotherapy compared with surgery. Cancer 88, 398-406 (2000).
3. Boice, J. D. Jr, Engholm, G., Kleinman, R. A., et al. Radiation dose and second cancers risk in patients treated for cancer of the cervix. Radiat Res 116, 3-55 (1988).
4. Nyandoto, P., Muhonen, T., Joensuu, H. Second cancers among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 42, 373-378 (1998).
5. Followill, D., Geis, P., Boyer, A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 38, 667-672 (1997).
6. Gray, L. H. Radiation biology and cancer. In: Cellular radiation biology: A symposium considering radiation effects in the cell and possible implications for cancer therapy, p. 8-25. Baltimore: William & Wilkins (1965).
7. Ron, E. Personal communication (2005).
8. Hall, E. J., Wuu, C. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56, 83-88 (2003).
9. Kry, S. F., Salehpour, M., Followill, D., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62, 1195-1203 (2005).
10. International Commission on Radiological Protection. Recommendations. Annals of the ICRP Publication 60. Oxford, England: Pergamon Press (1990).
11. Yan, X., Titt, U., Koehler, A. M., et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instr Meth in Phys Res A476, 429-434 (2002).
12. Hall, E. J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65, 1-7 (2006).
13. Gottschalk, B. Neutron dose in scattered and scanned proton beams; in regard to Eric Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 66, 1594 (2006).
14. Paganetti, H., Bortfeld, T., Delaney, T. F. Neutron dose in proton radiation therapy: in regard to Eric Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys 66, 1594 (2006).
15. Nolte, R., Muhlbradt, K.-H., Meulders, J. P., Stephan, G., Haney, M., Schmid, E. RBE of quasi-monoenergetic 60 MeV neutron radiation for induction of dicentric chromosomes in human lymphocytes. Radiat Environ Biophys 44, 201-209 (2005).
16. Schneider, U., Agosteo, S., Pedroni, E., et al. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53, 244-251 (2002).
17. MacDougall, R. H., Kerr, G. R., Duncan, W. Incidence of sarcoma in patients treated with fast neutrons. Int J Radiat Oncol Biol Phys 66, 842-844 (2006).